 Donald Schmid
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpes Zoster | 11 | 2024 | 319 | 1.420 |
Why?
| | Herpesvirus 3, Human | 12 | 2024 | 343 | 1.120 |
Why?
| | Chickenpox | 3 | 2016 | 84 | 0.530 |
Why?
| | Herpes Simplex | 2 | 2016 | 102 | 0.520 |
Why?
| | Simplexvirus | 1 | 2016 | 82 | 0.460 |
Why?
| | Skin Diseases | 1 | 2016 | 152 | 0.420 |
Why?
| | Herpes Zoster Vaccine | 2 | 2024 | 154 | 0.340 |
Why?
| | Chickenpox Vaccine | 1 | 2008 | 76 | 0.270 |
Why?
| | Meningitis | 1 | 2008 | 80 | 0.260 |
Why?
| | DNA, Viral | 4 | 2021 | 357 | 0.210 |
Why?
| | Genetic Variation | 1 | 2008 | 995 | 0.190 |
Why?
| | Immunocompromised Host | 2 | 2016 | 202 | 0.180 |
Why?
| | Arteritis | 1 | 2021 | 23 | 0.170 |
Why?
| | Virus Activation | 3 | 2011 | 97 | 0.160 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2021 | 48 | 0.160 |
Why?
| | Amyloid | 1 | 2021 | 96 | 0.160 |
Why?
| | Amyloid beta-Peptides | 1 | 2021 | 251 | 0.140 |
Why?
| | Antibodies, Viral | 4 | 2024 | 687 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2021 | 698 | 0.130 |
Why?
| | Encephalitis, Varicella Zoster | 2 | 2012 | 17 | 0.110 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2015 | 16 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 365 | 0.110 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2015 | 68 | 0.110 |
Why?
| | Viral Vaccines | 1 | 2015 | 107 | 0.100 |
Why?
| | Herpes Genitalis | 2 | 2004 | 17 | 0.100 |
Why?
| | Herpesvirus 2, Human | 2 | 2004 | 27 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 64 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1046 | 0.100 |
Why?
| | Herpesvirus 1, Human | 2 | 2011 | 87 | 0.090 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 106 | 0.090 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2012 | 31 | 0.090 |
Why?
| | Temporal Arteries | 1 | 2012 | 45 | 0.090 |
Why?
| | Facial Paralysis | 1 | 2011 | 23 | 0.090 |
Why?
| | Asymptomatic Infections | 1 | 2011 | 38 | 0.080 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 88 | 0.080 |
Why?
| | Leukocytosis | 1 | 2010 | 32 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2012 | 901 | 0.080 |
Why?
| | Vascular Diseases | 1 | 2012 | 252 | 0.080 |
Why?
| | Central Nervous System Infections | 1 | 2010 | 35 | 0.070 |
Why?
| | Brown-Sequard Syndrome | 1 | 2009 | 4 | 0.070 |
Why?
| | Skin Diseases, Viral | 1 | 2008 | 6 | 0.070 |
Why?
| | Astronauts | 1 | 2008 | 29 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2008 | 362 | 0.070 |
Why?
| | Virus Shedding | 1 | 2008 | 53 | 0.070 |
Why?
| | Genotype | 2 | 2008 | 1875 | 0.060 |
Why?
| | Humans | 16 | 2024 | 147293 | 0.050 |
Why?
| | Neutrophils | 1 | 2010 | 1135 | 0.050 |
Why?
| | Erythrocytes | 1 | 2010 | 749 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2024 | 61 | 0.050 |
Why?
| | Vaccines, Attenuated | 1 | 2024 | 129 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2023 | 137 | 0.050 |
Why?
| | Long-Term Care | 1 | 2024 | 118 | 0.050 |
Why?
| | Antibody Formation | 1 | 2023 | 288 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2024 | 280 | 0.040 |
Why?
| | Glycoproteins | 1 | 2023 | 358 | 0.040 |
Why?
| | Counseling | 1 | 2004 | 407 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 273 | 0.040 |
Why?
| | Vitamin D | 1 | 2024 | 405 | 0.040 |
Why?
| | Sexually Transmitted Diseases | 1 | 2002 | 168 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2024 | 586 | 0.040 |
Why?
| | Aged | 6 | 2024 | 26514 | 0.030 |
Why?
| | Recurrence | 2 | 2011 | 1151 | 0.030 |
Why?
| | Male | 9 | 2014 | 73950 | 0.030 |
Why?
| | HIV Infections | 1 | 2011 | 3235 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 522 | 0.030 |
Why?
| | Seroepidemiologic Studies | 2 | 2004 | 172 | 0.020 |
Why?
| | Child | 2 | 2014 | 22979 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 414 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2012 | 59 | 0.020 |
Why?
| | Optic Nerve | 1 | 2012 | 67 | 0.020 |
Why?
| | Cerebral Angiography | 1 | 2012 | 122 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 487 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2012 | 186 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1287 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2015 | 1140 | 0.020 |
Why?
| | Female | 8 | 2015 | 80076 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Vision Disorders | 1 | 2012 | 179 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2015 | 745 | 0.020 |
Why?
| | Adult | 6 | 2011 | 41405 | 0.020 |
Why?
| | Exanthema | 1 | 2011 | 86 | 0.020 |
Why?
| | Acyclovir | 1 | 2010 | 98 | 0.020 |
Why?
| | Adolescent | 4 | 2015 | 22825 | 0.020 |
Why?
| | Cell Count | 1 | 2010 | 321 | 0.020 |
Why?
| | Geniculate Ganglion | 1 | 2009 | 3 | 0.020 |
Why?
| | Superior Cervical Ganglion | 1 | 2009 | 5 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 3980 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2012 | 481 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1049 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1488 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4169 | 0.020 |
Why?
| | Pain | 1 | 2012 | 794 | 0.020 |
Why?
| | Saliva | 1 | 2008 | 252 | 0.010 |
Why?
| | Middle Aged | 4 | 2011 | 36821 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2133 | 0.010 |
Why?
| | Vaginosis, Bacterial | 1 | 2004 | 10 | 0.010 |
Why?
| | Trichomonas Infections | 1 | 2004 | 11 | 0.010 |
Why?
| | Condoms | 1 | 2004 | 102 | 0.010 |
Why?
| | Antiviral Agents | 1 | 2010 | 776 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2832 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4130 | 0.010 |
Why?
| | Risk Reduction Behavior | 1 | 2004 | 221 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2791 | 0.010 |
Why?
| | Brain | 1 | 2014 | 3009 | 0.010 |
Why?
| | Residence Characteristics | 1 | 2004 | 387 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 2136 | 0.010 |
Why?
| | Incidence | 1 | 2004 | 2954 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2010 | 11947 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 14437 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2011 | 17560 | 0.010 |
Why?
| | Risk Factors | 1 | 2004 | 11017 | 0.000 |
Why?
| | United States | 1 | 2002 | 16313 | 0.000 |
Why?
|
|
Schmid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|